Select Committee on Trade and Industry Twelfth Report


WITNESSES

Page
Tuesday 2 July 2002
Morning meeting
Mr John Mackie, British Venture Capital Association
Ev 1
Dr Linda Magee, Bionow, NWDA.
Ev 11
Tuesday 2 July 2002
Afternoon meeting
Dr Paul Drayson, Mr Crispin Kirkman, Mr Simon Best and Dr Paul Haycock BioIndustry Association.
Ev 17
Professor Peter Dunnill OBE, DSc, FREng, The Advanced Centre for Biochemical Engineering, University College, London
Ev 29

Monday 15 July 2002
Morning meeting
Mr Ken Snowden and Mr Liam Fennell, Scottish Enterprise.
Ev 34
Professor Grahame Bulfield CBE, FRSE, Roslin Institute
Ev 42
Professor Sir William Stewart FRS, FRSE, The Royal Society of Edinburgh
Ev 48
Dr Chris Latham, Pantherix Limited
Ev 51

Monday 15 July 2002
Afternoon meeting
Mr Paul McBarron, Cyclacel
Ev 57
Mr Harry Stratford, and Mr Adrian Gardner, Strakan
Ev 60
Mr Calum Paterson, Scottish Equity Partners
Ev 66

Thursday 7 November 2002
Dr Jeff Soloman, Eastern Region Biotechnology Initiative
Ev 70
Dr David Hardman, Babraham Bioscience Technologies Ltd
Ev 76
Dr Roland Kozlowski, Sense Proteomic
Ev 80
Dr Philip Dean, De Novo Pharmaceuticals
Ev 80
Dr John Brown and Mr Nick Higgins, Acambis
Ev 84

Tuesday 19 November 2002
Dr Philip Wright, Dr Alexander Duncan and Dr Gill Samuels, ABPI
Ev 88
Dr Greg Winter, CBE, MRC Laboratory of Molecular Biology, Cambridge
Ev 97
Dr Jeff Skinner, UCL Ventures
Ev 102
Dr Ederyn Williams, Warwick Ventures
Ev 102

Tuesday 17 December
Lord Sainsbury of Turville and Dr Monica Darnbrough, Department of Trade and Industry
Ev 108
Mr Anthony Milford, Dr Joe Anderson, Mr Richard Saunders, and Mr Derek Bartlett, Investment Management Association
Ev 118





 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2003
Prepared 3 September 2003